SMT Completes Enrollment in Multivessel TALENT Trial for Supraflex Cruz Stent
Oct 03, 2024
Mumbai (Maharashtra) [India], October 3: Sahajanand Medical Technologies (SMT) is excited to announce the successful completion of patient enrollment in the Multivessel TALENT trial, a cutting-edge study comparing SMT's Supraflex Cruz stent with the SYNERGY stent in patients with complex three-vessel coronary artery disease (3VD).
Read More...